Preventing or delaying the onset of end-stage kidney disease is vital. By implementing a results-driven, value-based approach, Dallas Nephrology Associates has demonstrated improved patient outcomes and value for payers.
Alexander Liang, MD
Advertisement
Articles by Alexander Liang, MD
Advertisement
Latest Updated Articles
Dallas Nephrology Associates’ Journey to Value-Based CarePublished: December 10th 2024 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
Weight Loss Medications Show Promise in MASLD, MASH
3
HMA Combination Therapy Boosts Survival in Accelerated- or Blast-Phase MPNs
4
Addressing Common Stigmas in Weight Loss: David Rometo, MD
5
